Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Boston Biomedical doses first patient in Phase l trial of DSP-0509

Endolymphatic sac tumour. Credit: Ed Uthman.

Go Top